Skip to main content

Table 1 Basic demographic and clinical characteristics and coagulation factors of patients before PEX therapy

From: Effects of preoperative plasma exchange therapy with albumin replacement fluid on blood coagulation in patients undergoing ABO-incompatible living-donor kidney transplantation using rotational thromboelastometry

  PEX (+) PEX (−) P value
Number of patients 13 15  
Age (year) 42.2 ± 13.9 45.9 ± 14.9 0.496
Weight (kg) 59.4 ± 12.5 66.0 ± 15.7 0.239
Body mass indexa 22.5 ± 4.0 23.5 ± 5.3 0.550
Anesthesia time (min) 415 ± 69.5 400 ± 87.2 0.601
Surgical time (min) 307 ± 55.9 299 ± 88.0 0.763
Male/female 6/7 10/5 0.445
Dialysis (%)a 53 40 0.705
Hypertension (%)a 92 87 1.000
Diabetic mellitus (%)a 23 40 0.435
Platelet (× 103/μl) 205.2 ± 61.3 233.8 ± 57.2 0.213
Fibrinogen (mg/dl) 322.8 ± 87.4 299.8 ± 65.8 0.496
Hemoglobin (g/dl) 11.7 ± 1.6 11.7 ± 1.6 0.995
Hematocrit (%) 35.1 ± 5.3 36.0 ± 4.8 0.647
  1. Data are presented as the ratio (%) and mean ± standard deviation. The two groups were compared using an unpaired t-test, unpaired t-test with Welch’s correction or aFisher’s exact test
  2. Abbreviations: % dialysis percentage of dialysis, BMI body mass index (weight (kg) / height squared (m2))